A 45-year-old socialite lady comes for cosmetic consultation and wants a remedy for dark circles and facial ageing. How do you manage this patient? Issues of dark circles and facial ageing should be addressed separately. Facial ageing should be considered...
In a recent discussion with colleagues, someone recognised that many, when asked what they do, say, “I am a doctor”. Rather than “I work as a doctor”. This sense of belonging, pride and duty comes with responsibility. Becoming a surgeon,...
This series explores the four pillars of advanced clinical practice and here, Rebecca Turner explores the pillar of clinical research. The role of the ophthalmic advanced nurse practitioner, as with all registered practitioners allied to ophthalmology, is on an upward...
2 October 2025
| Wanjiku (Ciku) Mathenge, Marcia Zondervan
|
EYE - General
Have you been wondering about how you can impact, or even just understand, the eyecare landscape in Africa from those who experience it daily? Ever wondered about which one body brings all eye health professionals in Africa together, united in...
Louise Robertshaw has been appointed as a trustee at Moorfields Eye Charity. She will also chair the charity’s fundraising and communications committee. Louise has considerable experience working at a senior level and as a trustee at national charities including in...
Guildford Rotary Eye Project (GREP) was conceived and implemented during the last 15 years with the sole aim to motivate and empower host Rotary clubs in India and Africa to resolve their problems with their own money. International partners in...
The world’s largest bioresource of eye images offers window into human health and serves as basis of a new AI foundation model to boost drug discovery. insitro, a machine learning-enabled drug discovery and development company, and the INSIGHT Health Data...
This comment article highlights the controversy that exists in the choice for anti-VEGF drugs used for treatment of macular oedema and wet age-related macular degeneration (AMD). Two existing licensed drugs for macular oedema are ranibizumab (Lucentis) and aflibercept (Eylea). A...
The College of Optometrists and The Royal College of Ophthalmologists (RCOphth) continue to review the ongoing impact of the pandemic on eye services across primary and secondary care.